In today's world, change is constant, shaping how people live, receive care, and engage with clinical research. In a growing number of trials, home visits now bring study procedures directly to patients' front doors. Yet amid this evolution, one principle remains unchanged: when a promise is made, people expect it to be kept.
Consider what that looks like in practice. A patient joins a trial, in part, because a clinician will come to their home for many of the study visits -- no long drives, no full days away from work. Then, midway through, the home visit vendor exits or a site cannot continue executing home visits -- creating uncertainty around how those visits will continue. When enrollment or retention concerns arise, sites should consider home visits as tool to leverage.
The protocol has not changed. The site has not changed. But the experience the patient agreed to at enrollment is now at risk -- and they had no say in it.
When home visits are included in a clinical trial, they become more than a protocol requirement; they become part of the promise patients and caregivers rely upon throughout their research journey. Home visits can reduce travel and provide the comfort of receiving care in familiar surroundings -- which matters even more for patients living with complex, chronic, or progressive conditions.
Still, mid-study change does happen. Contracts end. Vendors are replaced. Services transition. And while such disruptions may arise from circumstances beyond a sponsor’s control, disruption to the patient journey should be minimized.
The goal is not simply to replace a service. It is to preserve the patient experience.
At IQVIA, we recognize that maintaining continuity is more than an operational exercise. When timelines are compressed, swift logistics and a carefully coordinated transition plan are essential. Rapidly aligning sites, clinicians, training, documentation, and home visit logistics can help keep study activities moving forward with minimal disruption while preserving patients’ access to the vital services they have come to expect1. We rise to every challenge with speed and purpose, helping ensure patients receive the support they need without delay.
Done well, a transition is something the patient barely notices.
Operational models may evolve and organizations may change. Yet the commitments made to patients should endure. Perhaps the most important measure of success in clinical research is simple: keeping the promises made to patients.
References
1From Patient Insights to Site Level Results.pdf, IQVIA. Key themes include aligning patient insights, site readiness, and execution design, and the importance of operationalizing patient-centric strategies through structured planning and execution.
Related solutions
Bring trials directly to patients to improve access and engagement, increase quality and shorten timelines.
